(Q36115781)

12 August 2017

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence (English)

1 reference

12 August 2017

1 reference

8

1 reference

12 August 2017

9

Blomqvist C

1 reference

12 August 2017

4

von Smitten K

1 reference

12 August 2017

Jahkola T

1

1 reference

12 August 2017

Toivonen T

2

1 reference

12 August 2017

Virtanen I

3

1 reference

12 August 2017

Nordling S

5

1 reference

12 August 2017

von Boguslawski K

6

1 reference

12 August 2017

Haglund C

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

78

1 reference

12 August 2017

1507-1513

1 reference

12 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1998.714

12 August 2017

0 references

cites work

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Prognostic factors in early breast carcinoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers--a review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Tenascin in breast cancer development--is epithelial tenascin a marker for poor prognosis?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Local control following breast-conserving surgery for invasive cancer: results of clinical trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Prognostic factors for local recurrence in the conservatively treated breast cancer patient: a cautious interpretation of the data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Tenascin in mammary gland development: from embryogenesis to carcinogenesis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Enhanced tenascin expression in cervical and vulvar koilocytotic lesions

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Epithelial cells are an important source of tenascin in normal and malignant human breast tissue

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Randomized Clinical Trial to Assess the Effectiveness of Breast Irradiation Following Lumpectomy and Axillary Disection for Node-Negative Breast Cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Risk factors in breast-conservation therapy.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063217

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

23 September 2018

1 reference

12 December 2020

Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma

1 reference

12 December 2020

Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy

1 reference

12 December 2020

Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast

1 reference

12 December 2020

Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). Discriminants for 15-year survival. National Surgical Adjuvant Breast and Bowel Project Investigators

1 reference

12 December 2020

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

12 December 2020

Radiotherapy to the conserved breast: is it avoidable if the cancer is small?

1 reference

12 December 2020

Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer

1 reference

12 December 2020

p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis

1 reference

12 December 2020

Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

12 December 2020

S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome

1 reference

12 December 2020

Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis

1 reference

12 December 2020

Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance

1 reference

12 December 2020

Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.714

1 reference

12 August 2017

1 reference

12 August 2017

1 reference